These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34058143)

  • 1. Comparison of outcomes in patients with and without soft contact lens wear following Boston keratoprosthesis type 1.
    Liu J; Harissi-Dagher M
    Can J Ophthalmol; 2022 Jun; 57(3):154-160. PubMed ID: 34058143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of Boston keratoprosthesis type I: the Chinese People's Liberation Army General Hospital experience.
    Wang LQ; Wu TY; Chen XN; Xu ZQ; Yang M; Xiang R; Ma X; Zhang S; Huang YF
    Br J Ophthalmol; 2022 Jun; 106(6):781-785. PubMed ID: 33674425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glaucoma associated with Boston type I keratoprosthesis.
    Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
    Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic Vitritis after Boston Type 1 Keratoprosthesis Implantation: Incidence, Risk Factors and Outcomes in a Multicentric Cohort.
    Bonnet C; Chehaibou I; Ghaffari R; Jackson NJ; Bostan C; Hubschman JP; Harissi-Dagher M; Aldave AJ
    Ocul Immunol Inflamm; 2022 May; 30(4):769-775. PubMed ID: 33054501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
    Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
    Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada.
    Szigiato AA; Bostan C; Nayman T; Harissi-Dagher M
    Br J Ophthalmol; 2020 Nov; 104(11):1601-1607. PubMed ID: 32066560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratoprostheses in silicone oil-filled eyes: long-term outcomes.
    Iyer G; Srinivasan B; Agarwal S; Pattanaik R; Rishi E; Rishi P; Shanmugasundaram S; Natarajan V
    Br J Ophthalmol; 2019 Jun; 103(6):781-788. PubMed ID: 30021817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Term Outcomes of Pediatric Keratoprosthesis With the Near-Complete Conjunctival Flap.
    Bawany MH; Kudla C; Khan FA; Chung MM; Aquavella JV
    Cornea; 2021 Jun; 40(6):679-684. PubMed ID: 33941714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
    Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
    Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
    Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
    Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boston type I keratoprosthesis versus penetrating keratoplasty following a single failed corneal graft.
    El-Khoury J; Khair D; Daoud R; Thompson P; Racine L; Harissi-Dagher M
    Eye (Lond); 2023 Feb; 37(3):486-491. PubMed ID: 35169272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients.
    Geoffrion D; Hassanaly SI; Marchand M; Daoud R; Agoumi Y; Harissi-Dagher M
    Am J Ophthalmol; 2022 Mar; 235():249-257. PubMed ID: 34543660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes following primary versus secondary Boston keratoprosthesis type 1 implantation.
    Nayman T; Bostan C; Szigiato AA; Harissi-Dagher M
    Br J Ophthalmol; 2022 Jul; 106(7):935-940. PubMed ID: 33622700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
    Shah KJ; Cheung AY; Holland EJ
    Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endophthalmitis in Eyes With the Boston Type I Keratoprosthesis: Incidence, Recurrence, Risk Factors, and Outcomes.
    Bostan C; Nayman T; Szigiato AA; Morfeq H; Harissi-Dagher M
    Cornea; 2021 Oct; 40(10):1258-1266. PubMed ID: 33394754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mid-term prognosis of type I Boston keratoprosthesis reimplantation.
    Bouhout S; Robert MC; Harissi-Dagher M
    Br J Ophthalmol; 2022 Jan; 106(1):37-41. PubMed ID: 33055084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to achieve best postoperative visual acuity following Boston keratoprosthesis surgery.
    El-Khoury J; Mustafa M; Daoud R; Harissi-Dagher M
    Br J Ophthalmol; 2022 Jul; 106(7):929-934. PubMed ID: 33658233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
    Robert MC; Biernacki K; Harissi-Dagher M
    Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis.
    Aravena C; Yu F; Aldave AJ
    Cornea; 2018 Jan; 37(1):3-10. PubMed ID: 28990994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.